Danaher Corporation logo
Danaher Corporation (DHR)
Compare

DHR Income Statement

Revenue, expenses, and profitability analysis

DHR Quarterly Income Statement (USD)

Quarterly ReportTTM
03/27/2026
12/31/2025
09/26/2025
06/27/2025
03/28/2025
12/31/2024
09/27/2024
06/28/2024
15.035B3.591B3.966B3.523B3.955B3.526B3.890B3.401B3.428B
24.778B5.951B6.838B6.053B5.936B5.741B6.538B5.798B5.743B
Cost of Goods Sold
9.743B2.360B2.872B2.530B1.981B2.215B2.648B2.397B2.315B
60.3%60.3%58.0%58.2%66.6%61.4%59.5%58.7%59.7%
Total Operating Expenses
9.843B2.247B2.464B2.369B2.763B2.237B2.144B2.443B2.260B
1.606B387.000M438.000M378.000M403.000M379.000M442.000M383.000M391.000M
8.237B1.860B2.026B1.991B2.360B1.858B1.702B2.060B1.869B
5.192B1.344B1.502B1.154B1.192B1.289B1.746B958.000M1.168B
22.6%22.6%22.0%19.1%20.1%22.5%26.7%16.5%20.3%
4.339B1.235B1.373B1.076B655.000M1.129B1.315B977.000M1.083B
Interest Income
51.000M27.000M13.000M3.000M8.000M6.000M14.000M4.000M39.000M
256.000M63.000M55.000M67.000M71.000M72.000M61.000M87.000M65.000M
Other Income/Expense
-853.000M-109.000M-129.000M-78.000M-537.000M-160.000M-431.000M19.000M-85.000M
3.689B1.029B1.197B908.000M555.000M954.000M1.086B818.000M907.000M
650.000M206.000M176.000M168.000M100.000M175.000M229.000M159.000M176.000M
17.3%17.3%17.5%15.0%9.3%16.6%16.6%14.1%15.8%
6.690B1.537B2.051B1.765B1.337B1.792B1.971B1.655B1.728B
EBITDA Margin
25.8%25.8%30.0%29.2%22.5%31.2%30.1%28.5%30.1%
2.049B193.000M623.000M622.000M611.000M591.000M595.000M591.000M580.000M
EPS Basic
5.191.451.691.280.771.331.501.131.23
5.171.451.681.270.771.321.491.121.22
Shares Outstanding
707.900M707.900M707.300M710.700M716.500M716.300M731.000M723.000M737.600M
Diluted Shares Outstanding
711.200M711.200M711.000M713.700M719.100M720.800M737.200M729.400M742.400M

DHR Annual Income Statement (USD)

Annual Report
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
14.970B14.206B14.034B16.188B17.952B12.475B9.984B9.505B
24.568B23.875B23.890B26.643B29.453B22.284B17.911B17.049B
Cost of Goods Sold
9.598B9.669B9.856B10.455B11.501B9.809B7.927B7.543B
60.9%59.5%58.7%60.8%61.0%56.0%55.7%55.8%
Total Operating Expenses
9.833B9.022B8.755B8.652B9.902B8.163B6.621B6.435B
1.598B1.584B1.503B1.528B1.742B1.348B1.126B1.059B
8.235B7.438B7.252B7.124B8.160B6.815B5.495B5.376B
5.137B5.184B5.279B7.536B8.050B4.312B3.362B3.070B
20.9%21.7%22.1%28.3%27.3%19.4%18.8%18.0%
4.233B4.646B5.044B7.146B7.598B4.495B3.305B2.962B
Interest Income
30.000M117.000M303.000M41.000M11.000M71.000M139.000M9.200M
265.000M278.000M289.000M207.000M241.000M273.000M108.600M136.900M
Other Income/Expense
-904.000M-538.000M-235.000M-390.000M-452.000M183.000M-57.100M-108.200M
3.614B3.899B4.764B7.209B6.433B3.646B2.557B2.651B
619.000M747.000M823.000M818.000M1.251B849.000M873.000M555.600M
14.7%16.3%19.9%27.1%21.8%16.4%14.3%15.5%
6.945B7.276B7.499B9.485B10.007B6.543B4.603B4.277B
EBITDA Margin
28.3%30.5%31.4%35.6%34.0%29.4%25.7%25.1%
2.447B2.352B2.166B2.132B2.168B1.775B1.190B1.178B
EPS Basic
5.075.336.449.808.774.973.483.78
5.045.296.389.648.614.893.433.73
Shares Outstanding
707.300M731.000M736.500M725.100M714.600M706.200M715.000M700.600M
Diluted Shares Outstanding
711.000M737.200M743.100M737.100M736.800M718.700M725.500M710.200M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.

About Danaher Corporation

Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.

Washington, DC
61,000 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Rainer Blair